Popular Weight Loss Drugs No Longer in Shortage; FDA to Limit Cheaper Alternatives

By Chase Smith The FDA has officially removed popular weight loss drugs, including Lilly’s Mounjaro and Zepbound, from its drug shortage list, signaling the end of a nearly two-year period of scarcity that allowed compounding pharmacies to produce more affordable versions of these medications. “FDA confirmed with the drug’s manufacturer that their stated product availability and…

Source

Leave a Reply

Your email address will not be published.

Previous post Taxpayers Affected by Hurricane Helene Can Delay Their Tax Filing Deadline: IRS
Next post US Layoffs Up 53 Percent in September From Previous Year